AngioDynamics Inc. (ANGO)
NASDAQ: ANGOHealth CareMedical/Dental InstrumentsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
ANGO stock chart
Technical analysisKey statistics
All statistics- Market cap
- $454.61M
- EPS (TTM)
- -$0.78
- Dividend yield
- None
- 52-week range
- 9.39 – 16.29
- Day range
- 10.53 – 10.99
- Volume / Avg
- 430.34K / 651.16K
- Beta
- —
- Shares outstanding
- 42.05M
52-week range
ANGO stock today
On Nov 20, ANGO ended the session at $10.81, adding $0.05 (0.46%), versus the S&P 500's 3.70% decline. Shares are 33.6% below their 52-week high of $16.29, set on Aug 19, 2026 and 15.1% above the 52-week low of $9.39, in the middle of the past year's range. ANGO is down 15.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 9.5%.
AngioDynamics has posted a net loss over the last twelve months (EPS of -$0.78), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About AngioDynamics
Company profileAngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Device segments. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium.
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
- CEO
- Mr. Eric Honroth
- Headquarters
- Latham, NY
- Employees
- 632
- IPO year
- 2004
- Website
- angiodynamics.com
Financial highlights
Full financialsIn fiscal 2026, AngioDynamics generated $320.2 million in revenue, up 9.5% from fiscal 2025. AngioDynamics reported a net loss of $36.7 million, compared with a loss of $34.0 million a year earlier. Gross margin was 54.6% (up from 53.9%) and operating margin -12.5%.
| Fiscal year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Revenue | $320.17M | $292.50M | $303.91M | $338.75M | $316.22M |
| Growth | +9.46% | -3.76% | -10.28% | +7.13% | +8.66% |
| Net income | $-36.74M | $-33.99M | $-184.35M | $-52.44M | $-26.55M |
| EPS (diluted) | $-0.88 | $-0.83 | $-4.59 | $-1.33 | $-0.68 |
Analyst forecast
ForecastConsensus (4 analysts)
none
Avg. price target
$19.75+82.70%
- Strong buy 0
- Buy 4
- Hold 0
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Aug/2026)
- Oct 8, 2026
- EPS actual vs est.
- $-0.17 vs $-0.10
- Surprise
- -70.00%
ANGO news
All ANGO news- AngioDynamics, Inc. Shareholders Approve Amended 2020 Equity Incentive Plan at November 17, 2026 Annual MeetingNasdaq
- Reasons to Hold AngioDynamics Stock in Your Portfolio for NowNasdaqANGO, ISRG, WST, GKOS
- ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/YNasdaqANGO, WST, GMED, VCYT
- AngioDynamics (ANGO) Q1 2027 Earnings Call TranscriptNasdaq
- AngioDynamics anticipates $336M to $341M FY2027 net sales as CEO transition takes effect November 2Seeking Alpha
- Why AngioDynamics Crashed TodayNasdaq
- AngioDynamics Reiterates FY27 Outlook; Appoints Eric Honroth President And CEO - UpdateNasdaqANGO, ET
- AngioDynamics Names Honroth As CEO, Clemmer To Retire; Stock Down In PremarketNasdaqABT, ANGO, BDX, BSX
AngioDynamics peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| MDXGMiMedx Group Inc | 3.05 | -1.93% | $445.07M | vs ANGO |
| SENSSenseonics Holdings Inc. | 8.02 | -9.94% | $439.34M | vs ANGO |
| CARLCarlsmed Inc. | 17.42 | +1.16% | $477.38M | vs ANGO |
| SIShoulder Innovations Inc. | 20.15 | -0.79% | $421.58M | vs ANGO |
| RCELAvita Medical Inc. | 15.62 | -2.31% | $494.96M | vs ANGO |
| MOBIMobia Medical Inc. | 11.85 | -0.08% | $394.50M | vs ANGO |
| CERSCerus Corporation | 1.85 | -2.63% | $373.62M | vs ANGO |
| BWAYBrainsWay Ltd. ADR | 8.48 | -2.86% | $341.35M | vs ANGO |
Indexes, lists and sector
AngioDynamics stock FAQ
What is AngioDynamics's stock price today?
ANGO last traded at $10.81 as of Nov 20, 4:00 PM EST, up 0.46% on the day. Prices are delayed at least 15 minutes.
Who is AngioDynamics's CEO?
Mr. Eric Honroth is the chief executive officer of AngioDynamics Inc., which has about 632 employees.
What is the ANGO 52-week high?
The 52-week high for ANGO is $16.29 and the 52-week low is $9.39. The stock is currently 33.6% below its high.